These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32929414)

  • 21. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.
    Allen N; Brady M; Ni Riain U; Conlon N; Domegan L; Carrion Martin AI; Walsh C; Doherty L; Higgins E; Kerr C; Bergin C; Fleming C
    Front Med (Lausanne); 2021; 8():758118. PubMed ID: 35186963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of SARS-CoV-2-Specific Humoral and Cellular Immunity in Coronavirus Disease 2019 Convalescent Health Care Workers in Iraq.
    Hasan Ali I; Sahib Abdulamir A
    Arch Razi Inst; 2021 Nov; 76(5):1255-2127. PubMed ID: 35355770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No seroconversion among healthcare workers exposed to SARS-CoV-2 during the early phase of the pandemic.
    Fica A; Olivares F; Navarrete M; Martínez Pizzi G; Martínez Ulloa M; Castillo Fuentevilla K; Cornejo Morales T; Miranda Torres N; Velásquez Mejías JC; Luco Palomino D; Valenzuela Schneider D; Vásquez Barría N
    Rev Med Chil; 2023 Feb; 151(1):23-31. PubMed ID: 37906743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.
    McEllistrem MC; Clancy CJ; Buehrle DJ; Singh N; Lucas A; Sirianni V; Decker BK
    PLoS One; 2021; 16(3):e0248347. PubMed ID: 33735264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.
    Condom M; Mussetti A; Maluquer C; Parody R; González-Barca E; Arnan M; Albasanz-Puig A; Pomares H; Salas MQ; Carro I; Peña M; Clapes V; Baca Cano C; Oliveira Ramos AC; Sanz-Linares G; Moreno-González G; Mercadal S; Boqué C; Gudiol C; Domingo-Domènech E; Sureda A
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1358. PubMed ID: 33656801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-Care COVID-19 Antigen Testing in Exposed German Healthcare Workers-A Cost Model.
    Diel R; Hittel N; Nienhaus A
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Incidence Rate of SARS-CoV-2 Infection in Health Care Workers at a Dedicated COVID-19 Hospital: Experiences of the Pandemic from a Large Mexican Hospital.
    Bueno-Hernández N; Carrillo-Ruíz JD; Méndez-García LA; Rizo-Téllez SA; Viurcos-Sanabria R; Santoyo-Chávez A; Márquez-Franco R; Aguado-García A; Baltazar-López N; Tomita-Cruz Y; Barrón EV; Sánchez AL; Márquez E; Fossion R; Rivera AL; Ruelas L; Lecona OA; Martínez-Mekler G; Müller M; Arroyo-Valerio AG; Escobedo G
    Healthcare (Basel); 2022 May; 10(5):. PubMed ID: 35628032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
    Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
    Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study.
    Stemler J; Kramer T; Dimitriou V; Wieland U; Schumacher S; Sprute R; Oberste M; Wiesmüller G; Rau H; Pieper S; Bethe U; Lehmann C; Hellmich M; Klein F; Langebartels G; Cornely OA
    Infection; 2022 Jun; 50(3):607-616. PubMed ID: 34669164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of social contacts on SARS-CoV-2 exposure among healthcare workers.
    Emecen AN; Keskin S; Boncukcu Eren E; Yildirim Ustuner B; Celik SG; Suner AF; Sezgin E; Siyve N; Basoglu Sensoy E; Tutal Altas E; Demiral Y
    Occup Med (Lond); 2022 Jan; 72(1):10-16. PubMed ID: 34633044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Exposure from Health Care Workers to Infants: Effects and Outcomes.
    Shaiba LA; Hadid A; Abdulghani SH; Hussain SA; Shah PS
    Am J Perinatol; 2023 May; 40(7):799-806. PubMed ID: 34450672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.
    Johannesen CK; Rezahosseini O; Gybel-Brask M; Kristensen JH; Hasselbalch RB; Pries-Heje MM; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Jensen CAJ; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Dessau RB; Sørensen E; Harritshøj LH; Folke F; Sten C; Møller MEE; Engsig FN; Ullum H; Jørgensen CS; Ostrowski SR; Bundgaard H; Iversen KK; Fischer TK; Nielsen SD
    Microbiol Spectr; 2021 Oct; 9(2):e0090421. PubMed ID: 34668738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcomes of healthcare workers with COVID-19 pre- and postvaccination.
    Filho FFD; Chaves EBM; D'Avila KG; Neyeloff JL; Dos Santos RP; Silva DR
    J Med Virol; 2022 Nov; 94(11):5279-5283. PubMed ID: 35831246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High seroprevalence of SARS-CoV-2 antibodies in healthcare workers in COVID-19 wards indicates an occupational hazard-a prospective cohort study during the first year of the COVID-19 pandemic in Kalmar County, Sweden.
    Hultqvist V; Bonnedahl J; Edwardsson J; Tjernberg I; Rydén I
    APMIS; 2023 Sep; 131(9):491-497. PubMed ID: 37462243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.
    Schaffrath J; Brummer C; Wolff D; Holtick U; Kröger N; Bornhäuser M; Kraus S; Hilgendorf I; Blau IW; Penack O; Wittke C; Steiner N; Nachbaur D; Thurner L; Hindahl H; Zeiser R; Maier CP; Bethge W; Müller LP
    Transplant Cell Ther; 2022 Jun; 28(6):337.e1-337.e10. PubMed ID: 35296445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
    La Rosa C; Chiuppesi F; Park Y; Zhou Q; Yang D; Gendzekhadze K; Ly M; Li J; Kaltcheva T; Ortega Francisco S; Gutierrez MA; Ali H; Otoukesh S; Amanam I; Salhotra A; Pullarkat VA; Aldoss I; Rosenzweig M; Aribi AM; Stein AS; Marcucci G; Dadwal SS; Nakamura R; Forman SJ; Al Malki MM; Diamond DJ
    Front Immunol; 2023; 14():1114131. PubMed ID: 36936918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.